Safety and efficacy of uninterrupted periprocedural rivaroxaban in patients undergoing atrial fibrillation catheter ablation: A metaanalysis of 1,362 patients.

Authors

Jalaj Garg MD, Lehigh Valley Health NetworkFollow
Rahul Chaudhary MD
Parasuram Krishnamoorthy MD
Neeraj Shah MD, Lehigh Valley Health NetworkFollow
Andrea Natale MD, FACC, FHRS, FESC
Babak Bozorgnia MD, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

1-15-2016

Volume

203

First Page

906

Last Page

908

ISSN

1874-1754

Published In/Presented At

Garg, J., Chaudhary, R., Krishnamoorthy, P., Shah, N., Natale, A., & Bozorgnia, B. (2015). Safety and efficacy of uninterrupted periprocedural rivaroxaban in patients undergoing atrial fibrillation catheter ablation: A metaanalysis of 1,362 patients. International Journal Of Cardiology, 203906-908. doi:10.1016/j.ijcard.2015.11.085.

Disciplines

Cardiology | Medical Sciences | Medical Specialties | Medicine and Health Sciences

PubMedID

26618251

Department(s)

Department of Medicine, Cardiology Division, Department of Medicine Faculty

Document Type

Article